New artificial tears put to the test for dry eye sufferers

NCT ID NCT07238699

First seen Jun 24, 2026 · Last updated Aug 12, 2026 · Updated 5 times

Summary

This study is testing two new artificial tear formulas to see if they are safe and well-tolerated in people with moderate dry eye disease. Researchers will monitor for side effects and eye health in 148 participants who already use artificial tears. The goal is to find better options for managing dry eye symptoms.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
artificial tear formulations (FID123440 and FID123437)
What this could lead to
If successful, this could lead to new, well-tolerated artificial tears for people with dry eye disease.
What could go wrong
This is an early safety study, not designed to prove the drops work better than existing ones. The new formulations may not be more effective or could cause unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Deakin Collaborative Eye Care Clinic, Deakin University

    Waurn Ponds, Victoria, 3216, Australia

  • Ophthalmic Trials Australia

    Teneriffe, Queensland, 4005, Australia

  • School of Optometry and Vision

    Sydney, New South Wales, 2052, Australia

  • The University of Melbourne, Department of Optometry and Vision Science

    Carlton, Victoria, 3053, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.